Novel nitroimidazoles with trypanocidal and cell growth inhibition activities

Cytobios

Volumn 2001, Issue 409, 2001, Pages 83-90

  Boechat, N ^a   Carvalho, A S ^a,c   Fernandez Ferreira, E ^b   Soares, R O A ^b   Souza, A S ^a   Gibaldi, D ^b,c   Bozza, M ^b,c   Pinto, A C ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Laboratory of Applied Pharmacology   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cancer; Nitroimidazole derivative; Trypanosoma cruzi

Indexed keywords

5 (N (3 (5 TRIFLUOROMETHYL) 1H 1,2,4 TRIAZOLYL))AMINO 1 METHYL 4 NITROIMIDAZOLE; 5 N (1 PYRAZOLYL) 1 METHYL 4 NITROIMIDAZOLE; 5-(N-(3-(5-TRIFLUOROMETHYL)-1H-1,2,4-TRIAZOLYL))AMINO-1-METHYL-4-NITROIMIDAZOLE; 5-N-(1-PYRAZOLYL)-1-METHYL-4-NITROIMIDAZOLE; ANTITRYPANOSOMAL AGENT; NITROIMIDAZOLE DERIVATIVE;

ANIMAL; ARTICLE; CELL CULTURE; CHAGAS DISEASE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ERYTHROCYTE; GROWTH, DEVELOPMENT AND AGING; MONOCYTE; MOUSE; MULTIPLE MYELOMA; PARASITOLOGY; SHEEP; SYNTHESIS; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; MICE; MONOCYTES; MULTIPLE MYELOMA; NITROIMIDAZOLES; SHEEP; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; TUMOR CELLS, CULTURED;

EID: 0035237226     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BOECHAT N., Barbosa J. P., Macedo M. G. and Pinto A. C. 1998. Twelfth European Symposium on Fluorine Chemistry. Berlin, Germany, p 1.
2. BRUNDTLAND G. H. 1999. Burden of infectious disease. World Health Organization Report on infectious disease.
3. CARVALHO A. S., Fraga C. A. M. and Barreiro E. J. 1996. Synthesis of condensed tricyclic pyrazolo[3,4-b]thieno[2,3-d]pyridine and related isostere derivatives. J. Heterocyclic Chem. 33 309-13.
4. Do CAMPO R. 1990 Sensitivity of parasites to free radical damage by anti-parasitic drugs. Chem. Biol. Interact. 73 1-27.
5. FERREIRA R. C. and Ferreira L. C. S. 1986. Mutagenicity of CL 64 855, a potent anti-Trypanosoma cruzi drug. Mutat. Res. 171 11-5.
6. HEINDEL N. D., Lacey C. J., Egolf R., Mease B. N. and Schray K. J. 1986. A controlled-oxidation synthesis of substituted aryl 1-methyl-4-nitro-5-imidazolyl sulfones. J. Heterocyclic Chem. 23 1087-90.
7. HORI H., Noguchi N., Yokoyama H., Ise H., Jin C., Kesai S., Goto T. and Taiara Z. 1996. Design and synthesis of new mitochondrial cytotoxin N-triadiazolyl-anilines that inhibit tumor cell growth. Bioorg. Med. Chem. 4 247-53.
8. JOSEPHY P. D. and Mason R. P. 1985. Bioactivation of Foreign Compounds. p 451. Edited by M. W. Anders. Academic Press, New York.
9. KEDDERIS G. L. and Miwa G. T. 1988. The metabolic activation of nitroheterocyclic therapeutic agents. Drug Metab. Rev. 19 33-62.
10. KINNAMON K. E., Poon B. T., Hanson W. L. and Waits V. B. 1998. Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus). Expl Parasitol. 89 251-6.
11. MALANGA C. M., Conroy J. and Cuckler A. C. J. 1981. Therapeutic efficacy of several nitroimidazoles for experimental Trypanosoma cruzi infections in mice. J. Parasitol. 67 35-40.
12. MORENO S. N. J. and do Campo R. 1985. Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis. Environ. Hlth Perspect. 64 199-208.
13. MUKHERJEE A., Kumar S., Seth M. and Bhaduri A. P. 1989. Synthesis of 1-methyl-4-nitro-5-substituted-imidazole and substituted imidazolothiazole derivatives as possible antiparasitic agents. Indian J. Chem. 283 391-6.
14. MURRAY P. K., Habbersett M. C. and Meurer R. D. 1983. Trypanosoma cruzi: efficacy of the 2-substituted-5-nitroimidazoles, MK-436 and L634,549, in tissue culture and mice. Am. J. trop. Med. Hyg. 32 1242-50.
15. NAGARAJAN K., Arya V. P., Shah R. K., Shenoy S. J. and Bhat G. A. 1982. Nitroimidazoles: part VI. N-(1-alkyl-5-nitroimidazol-2-yl)-heteroarenes. Indian J. Chem. 21B 945-8.
16. NAITO Y., Akahoshi F., Takeda S., Okada T., Kajii M., Nishimura H., Sugiura M., Fukaya C. and Kagitani Y. 1996. Synthesis and pharmacological activity of triazole derivatives inhibiting eosinophilia. J. med. Chem. 39 3019-29.
17. SCOTT V. R. and Matthews T. R. 1987. The efficacy of an N-substituted imidazole, RS-49676, against a Trypanosoma cruzi infection in mice. Am. J. trop. Med. Hyg. 37 308-13.
18. VOOGD C. E., Van der Stel J. J. and Jacobs J. J. J. A. A. 1979. The mutagenic action of nitroimidazoles. IV. A comparison of the mutagenic action of several nitroimidazoles and some imidazoles. Mutat. Res. 66 207-21.
19. WALSH J. S., Wang R., Bagan E., Wang C. C., Wislocki P. and Miwa G. T. 1987. Structural alterations that differentially affect the mutagenic and antitrichomonal activities of 5-nitroimidazoles. J. med. Chem. 30 150-6.